Leveraging pre-vaccination antibody titres across multiple influenza H3N2 variants to forecast the post-vaccination response
NIAID, UCSD PREPARE Institute, LJI & Kyowa Kirin, Inc. (KKNA-Kyowa Kirin North America), UGA, Cleveland Clinic, the Georgia Research Alliance, and the Bodman family.
Authors
- Tal Einav (ORCID: https://orcid.org/0000-0003-0777-1193)
- Shane Crotty (ORCID: https://orcid.org/0000-0002-6484-6262)
- Ted M. Ross (ORCID: https://orcid.org/0000-0003-1947-7469)
- Hannah B. Hanley
- James D. Allen (ORCID: https://orcid.org/0000-0002-3798-706X)
- Michael A. Carlock (ORCID: https://orcid.org/0000-0003-4077-7386)
- Hannah D. Stacey (ORCID: https://orcid.org/0000-0001-6218-0762)
Institutions
- La Jolla Institute for Immunology (US)
- University of Georgia (US)
Publication Details
- Journal
- EBioMedicine
- Published
- 2025-05-26
- DOI
- https://doi.org/10.1016/j.ebiom.2025.105744
- Citations
- 5
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 6.77
Funders
- Emory University
- Cleveland Clinic
- Georgia Research Alliance
- National Institutes of Health
- Centers for Disease Control and Prevention
- University of California, San Diego
- National Institute of Allergy and Infectious Diseases
- National Center for Advancing Translational Sciences